Related Experiment Video
Updated: Jul 2, 2026

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues
Published on: April 5, 2018
Chromatin, cancer and drug therapies
Connie C Cortez1, Peter A Jones
1Department of Urology, University of Southern California, Los Angeles, CA 90089-9181, USA.
Abstract:
The structure and organization of chromatin have attracted a great deal of attention recently because of their implications for the field of epigenetics. DNA methylation and the post-translational modifications that occur on histones can specify transcriptional competency. During cancer development, tumor suppressor genes become silenced by DNA hypermethylation and chromatin modifiers no longer perform in their usual manner. Current epigenetic therapy has been able to take advantage of the reversibility of these epimutations. Progress has been made in the treatment of hematological malignancies and some solid tumors. As the knowledge of how chromatin regulates gene expression is enhanced, improvements in the treatment of cancer can be made.
Insights
Epigenetics, the study of gene expression changes, reveals how DNA methylation and histone modifications impact cancer. Epigenetic therapy offers reversible treatments, showing promise in hematological malignancies and solid tumors.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Chromatin structure and organization are crucial in epigenetics.
- DNA methylation and histone modifications regulate gene expression.
- Aberrant epigenetic modifications are implicated in cancer development.
Purpose of the Study:
- To explore the role of chromatin organization in epigenetics and cancer.
- To highlight the therapeutic potential of targeting epigenetic alterations.
- To discuss the implications of epigenetic research for cancer treatment.
Main Methods:
- Review of current literature on chromatin, epigenetics, and cancer.
- Analysis of DNA methylation and histone modification mechanisms.
- Examination of epigenetic therapy strategies and their outcomes.
Main Results:
- Epigenetic alterations, including DNA hypermethylation, silence tumor suppressor genes in cancer.
- Epigenetic therapies leverage the reversibility of epimutations.
- Significant progress has been observed in treating hematological malignancies and some solid tumors.
Conclusions:
- Understanding chromatin's role in gene regulation is key to advancing cancer treatment.
- Epigenetic therapies represent a promising avenue for cancer intervention.
- Further research into epigenetic mechanisms will drive improved cancer therapies.
Related Concept Videos
Treatment Resistant Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

